Frovatriptan Succinate recalls

Frovatriptan Succinate products have been recalled 1 time, most recently on 16 Apr 2025. The recalling company is usually Glenmark Pharmaceuticals Inc., USA. The most common reason is manufacturing (cgmp) deviations.

Total recalls1since 2025

Last 12 months0reported

Class I00% of total

Ongoing1latest 16 Apr 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 1 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why frovatriptan succinate is recalled

Manufacturing (CGMP) Deviations1100%

Companies

Glenmark Pharmaceuticals Inc., USA1100%

By year

20251100%

Ongoing frovatriptan succinate recalls

1 active

Reported	Class	Recall	Company	Reason	Where
16 Apr 2025Drug	CLASS II	Frovatriptan Succinate Tablets 2.5mg recalledFrovatriptan Succinate	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide

All frovatriptan succinate recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
16 Apr 2025Drug	CLASS II	Frovatriptan Succinate Tablets 2.5mg recalledFrovatriptan Succinate	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.